Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Other Non-Current Liabilities (2022 - 2023)

Sagimet Biosciences' Other Non-Current Liabilities history spans 2 years, with the latest figure at $1000.0 for Q3 2023.

  • Quarterly Other Non-Current Liabilities changed N/A to $1000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Sep 2023, changed N/A year-over-year, with the annual reading at $4000.0 for FY2022, N/A changed from the prior year.
  • Other Non-Current Liabilities came in at $1000.0 for Q3 2023, down from $5000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $5000.0 in Q2 2023 to a low of $1000.0 in Q3 2023.